The firm pleased to announce that Jeffrey I. D. Lewis has been elected as the President-Elect of the American Intellectual Property Law Association (AIPLA). Mr. Lewis has been an active member of AIPLA for over 20 years, is a frequent presenter at AIPLA conferences, and has been a member of AIPLA Board of Directors, Chairman of the Patent Litigation Committee and its Markman Subcommittee on Claim Interpretation, and Vice Chairman of the Patent Law Committee. He was named an AIPLA Fellow in 2007. AIPLA criteria for being named a Fellow are outstanding service to the association, prominence within the intellectual property profession, learned contributions to the profession, and observance of the highest standards of ethical conduct.
AIPLA is a national bar association formed to maintain a high standard of professional ethics, to aid in the improvement in laws relating to intellectual property and in their proper interpretation by the courts, and to provide legal education to the public and to its members on intellectual property issues. Its membership consists of lawyers in private and corporate practice, government services and the academic community. AIPLA represents a wide spectrum of companies and institutions that are involved directly and indirectly in the practice of patent, trademark, copyright and unfair competition law.
Mr. Lewis, a Chemical Engineer, is a member of the firm and a Registered Patent Attorney concentrating his practice in patent litigation. He represents both patentees and accused infringers in all aspects of patent litigation. He has represented chemical and pharmaceutical companies, including the pharmaceutical innovator in numerous Abbreviated New Drug Application (ANDA) patent litigations and also has represented companies in many other technology areas. He also regularly counsels clients on intellectual property matters, including providing formal opinions, and represents them in transactions. Mr. Lewis has been recognized by “Chambers USA,” “Super Lawyers” and “The International Who's Who of Life Sciences Lawyers” in the area of Intellectual Property.